Efficacy and Safety of Moxonidine in Indian Patients

Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00160277

Enrollment

100

Registered

2005-09-12

Start date

2005-07-31

Completion date

Unknown

Last updated

2009-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Efficacy and safety of moxonidine in Indian hypertensives

Brief summary

The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.

Interventions

DRUGMoxonidine

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Hypertension

Exclusion criteria

Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina

Design outcomes

Primary

Measure	Time frame
Systolic blood pressure reduction	—

Secondary

Measure	Time frame
Piggy-back pharmacoeconomic evaluation; Safety and tolerability	—

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026